If a retail pharmacy just quoted you $1,000 to $1,500 a month for Wegovy or Zepbound, the picks below are the eight cash-pay paths that actually work in 2026. The best GLP-1 without insurance is not the cheapest sticker price. It is the path where you finish month one and refill month two without a melted ice pack, a 45-day refill miss, or a fake cancel button.
The 2026 cash floor is much lower than that retail quote. Brand-name direct-to-consumer is now real: LillyDirect Zepbound vials at $299 to $449 a month, NovoCare Wegovy injection at $249 on the 12-month plan, Wegovy Pill at $149, and Foundayo (the new oral from Lilly) at $149. Compounded telehealth is still legal under the 503A patient-specific exception, narrowed after the FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025. TrumpRx.gov is live as of February 2026, with brand-name semaglutide around $350 a month and no income test.
The eight picks below are matched to eight reader situations. Brand-name DTC sits next to compounded because in 2026 the gap has closed.
Here are the eight paths.
Top Picks Comparison Table
| Provider | Best For | Starting Price | Patient-First Score | Apply Now |
|---|---|---|---|---|
| Wegovy Pill via NovoCare | Cheapest Brand-Name GLP-1 Overall, If You Can Live With the Food Rules | $149/mo | — | — |
| Found | Newest Oral Pill, No Food or Water Restrictions | $149/mo | 10 / 100 | See Offer |
| Pomegranate | Cheapest Compounded Path With Full Pharmacy Transparency | $119/mo | 86 / 100 | See Offer |
| Goby Meds | Best Pre-Payment Pharmacy and Additive Disclosure | $169/mo | 78 / 100 | See Offer |
| Enhance.MD | Best Compounded Path When You Want Real Clinical Oversight | $249/mo | 91 / 100 | See Offer |
1. LillyDirect Zepbound Vials at Starter Dose: Best Brand-Name Path When You’re Just Starting
You want Lilly’s own vial, not a copy. You want a price you can predict. LillyDirect at 2.5mg is $299 a month.
- True monthly cost: $299/mo at 2.5mg (Self Pay Journey Program)
- Channel: LillyDirect home delivery or Walmart Pharmacy pickup (~4,600 locations, launched Oct 29, 2025)
- Eligibility: Valid on-label Zepbound Rx (BMI 30+, or 27+ with comorbidity). Not for Medicare/Medicaid.
- Refill discipline: 45-day window required to keep this price
This is for the reader who does not want to vet which 503A pharmacy a telehealth provider is using, and who wants cold chain handled by Lilly’s own infrastructure. At $299 a month, the starter dose is in the same band as GobyMeds compounded tirzepatide at $299, and only about $100 to $120 above Pomegranate‘s BPI Labs compounded tirzepatide at $179 to $199. You give up the cheapest possible per-month number. You get brand-name quality assurance, manufacturer cold-chain, and zero pharmacy-vetting work.
How it runs. Any prescriber (your PCP or a telehealth provider) routes the prescription to LillyDirect Self Pay Pharmacy Solutions through their EHR. You pick home delivery through GiftHealth or Fuze Health, or you pick Walmart pickup at one of roughly 4,600 locations launched October 29, 2025. Same pricing either channel. No telehealth subscription is needed on top.
The 45-day refill is the trap. Mark the calendar from the delivery date, not from when you ran out. Miss it on 2.5mg and you reset to the non-program price on your next order. The penalty is smaller at starter dose than at maintenance, but the discipline starts here. Most patients who fail this rule miss it at the dose transition, not at steady state.
One state-availability note. LillyDirect ships within the U.S. only and state telehealth prescriber rules apply. Confirm your state at signup.
Best if you want brand-name certainty at the starter dose and you can keep a calendar.
[CTA: See current pricing →]
2. LillyDirect Zepbound Vials at Maintenance Dose: Best Flat-Rate Brand-Name Path at 7.5mg and Up
7.5mg costs the same as 15mg. $449 a month, flat, no dose-escalation penalty.
- True monthly cost: $449/mo flat (7.5mg, 10mg, 12.5mg, 15mg)
- 5mg sits at $399/mo
- Channel: LillyDirect home delivery or Walmart pickup
- Refill discipline: 45-day window or pricing jumps to $599 (7.5mg), $699 (10mg), $849 (12.5mg), $1,049 (15mg)
- Eligibility: BMI 30+ or 27+ with comorbidity. Not for Medicare/Medicaid.
This is the path for readers who have titrated past starter dose and want brand-name without per-mg price escalation. Most compounded providers nudge price up as dose climbs. Eden semaglutide goes from $149 first month to $229 ongoing. Pomegranate BPI Labs tirzepatide moves from $179 starter to $199 advanced. ShedRx‘s LillyDirect-routed Zepbound shows $299 first, $399 second, $499 third dose on, which suggests some intermediaries mark up above Lilly’s direct pricing. LillyDirect at maintenance is the only brand-name option in this article that holds one flat number across four dose strengths.
The number that matters: at 15mg, missing the 45-day window costs you an extra $600 a month. That penalty math is the operative number for this pick. At maintenance, calendar discipline pays for groceries. At 12.5mg the miss is +$400. At 10mg, +$250. At 7.5mg, +$150. None of those numbers are small.
How it runs is identical to Pick 1. Prescriber routes Rx to LillyDirect, choose Walmart or home delivery, set two calendar reminders (Day 30 to reorder, Day 40 to follow up if nothing shipped). LillyDirect is not auto-ship. You must actively refill each cycle.
Skip this path if you cannot reliably refill on a 45-day cadence. At 15mg the penalty is +$600 a month. At that point compounded tirzepatide at GobyMeds or Pomegranate is the safer floor.
[CTA: See current pricing →]
3. Wegovy Pill via NovoCare: Cheapest Brand-Name GLP-1 Overall, If You Can Live With the Food Rules
$149 a month for FDA-approved semaglutide. No needles. The catch is in the next paragraph.
- True monthly cost: $149/mo for 1.5mg and 4mg through August 31, 2026 (then 4mg becomes $199/mo)
- Higher doses: 9mg and 25mg at $299/mo
- Channel: NovoCare Pharmacy direct, or Walgreens, Walmart, Costco at the Novo cash price
- Multi-month (Ro, WeightWatchers, LifeMD, Hims, Sesame): 3-month $289/mo, 6-month $269/mo, 12-month $249/mo
- Eligibility: Valid Wegovy Rx (BMI 30+, or 27+ with comorbidity). Excluded for Medicare/Medicaid from savings offers.
The food rule is the friction. Wegovy Pill must be taken 30 minutes before food, with plain water only. No coffee, no juice, no other beverage. Same Rybelsus protocol. Patients who travel for work, who have unpredictable mornings with kids, or who already struggle with adherence will skip doses and lose efficacy. There is no workaround. The molecule is degraded by stomach acid without an empty fasted stomach.
How it runs. Any prescriber writes a Wegovy Pill Rx and routes to NovoCare Pharmacy specifically (the brand name matters here). You set up the account by phone or text. You pay $149 a month direct. The same Novo cash price is also available at Walgreens, Walmart, Costco, and via GoodRx, so you can pick up at retail if NovoCare home delivery doesn’t fit. If you’d rather commit to 12 months for predictability, route through Ro, WeightWatchers, LifeMD, Hims, or Sesame at $249 a month.
Two budget notes. The $149 price for 4mg ends August 31, 2026. Plan for $199 a month after that date. And oral semaglutide is roughly 1% bioavailable compared to subcutaneous injection. Some patients report milder appetite suppression at equivalent oral dose. Not a reason to skip the pill. Worth calibrating expectations.
Best if you want brand-name semaglutide, you’d rather a pill than a needle, and your morning routine already supports a 30-minute empty-stomach window.
[CTA: See current pricing →]
4. Foundayo (Orforglipron) via LillyDirect: Newest Oral Pill, No Food or Water Restrictions
FDA approved April 1, 2026. Available through LillyDirect five days later. No food rules, no water rules. The drug is also brand new.
- True monthly cost: $149/mo for lowest dose via LillyDirect cash self-pay
- Higher doses: up to $349/mo
- 45-day refill window: $299/mo if maintenance pricing missed
- Medicare Part D eligible: $50/mo starting July 1, 2026
- Channel: LillyDirect, retail pharmacies, telehealth partners
- Differentiator: No food/water restrictions (unlike Wegovy Pill)
Foundayo is orforglipron, a non-peptide GIP/GLP-1, a different drug class than semaglutide. Take it any time of day, with or without food, with any beverage. For readers who looked at Wegovy Pill’s 30-minute fasting window and thought “I will skip doses,” Foundayo removes that adherence trap.
How it runs is the same LillyDirect Self Pay infrastructure that handles Zepbound vials. Any prescriber writes orforglipron, routes the Rx to LillyDirect or a participating telehealth partner. Same 45-day refill discipline.
The caveat is data. Semaglutide has five-plus years of real-world weight-loss outcome data. Tirzepatide has four-plus. Orforglipron has weeks. The Phase 3 program supporting FDA approval was strong on weight loss and safety endpoints. The long-tail signal (rare adverse events, drug interactions, durability beyond 12 months in routine use) is not yet visible. That gap will close fast. Today it is still a gap.
One Medicare note worth flagging. The $50/mo Part D pricing on Foundayo kicks in July 1, 2026, which makes this the cheapest brand-name GLP-1 path for Medicare patients once that date arrives. Before July, Medicare beneficiaries cannot use the $149/mo cash-pay offer. State availability may vary at launch, so confirm at signup.
Foundayo vs Wegovy Pill: same price, no food rules, less long-term data. Pick Foundayo if a fasting window would tank your routine. Pick Wegovy Pill if you want the more established molecule.
[CTA: See current pricing →]
5. NovoCare Wegovy Injection on the 12-Month Plan: Best Brand-Name Injectable Path
Wegovy injection at retail: $1,350 a month. NovoCare 12-month plan: $249 a month. Same drug.
- True monthly cost: $249/mo on 12-month commitment
- 6-month: $299/mo
- 3-month: $329/mo
- Standard month-to-month: $349/mo for 0.25mg-2.4mg; $399/mo for Wegovy HD 7.2mg
- Introductory: $199/mo for first 2 fills of 0.25mg and 0.5mg through June 30, 2026
- Channel: NovoCare Pharmacy (requires existing Wegovy Rx from your provider)
- Eligibility: Valid Wegovy Rx; not for Medicare/Medicaid for savings
This is Novo Nordisk’s March 31, 2026 response to LillyDirect. The 12-month commitment brings brand-name Wegovy injection into rough parity with maintenance-dose LillyDirect Zepbound ($449/mo) on a per-month basis. Injectables require a prior provider Rx, unlike LillyDirect’s more direct path. The trade-off is the lock-in, and the upside is the form factor: injection has 99% bioavailability versus oral semaglutide’s roughly 1%.
How it runs. You already have a Wegovy Rx from a PCP or telehealth provider. You route the Rx to NovoCare Pharmacy. At checkout you pick 3-month ($329/mo), 6-month ($299/mo), or 12-month ($249/mo) commitment. Longer commitment, lower per-month cost. If you’re brand new to Wegovy and starting at 0.25mg or 0.5mg, the introductory $199/mo first-two-fills offer runs through June 30, 2026 and stacks separately from the subscription math.
Two things to verify before signing. First, NovoCare does not write prescriptions. You need the Rx already in hand from your own provider. Second, if side effects force you off the drug in month three, refund mechanics on a 12-month prepay are not trivial. Read the refund policy before committing 12 months upfront. Government beneficiaries (Medicare/Medicaid) are excluded from the savings pricing entirely.
Best if you want brand-name Wegovy injection, you’ve already decided injection over pill, and you’re confident you’ll stay on the drug 12 months.
[CTA: See current pricing →]
6. Pomegranate: Cheapest Compounded Path With Full Pharmacy Transparency
Five pharmacy partners listed by name. Pricing by pharmacy and by dose, visible before you sign up.
- True monthly cost: $119/mo semaglutide (Empower, 0-1mg); $149/mo (1.1-2.5mg)
- Tirzepatide (BPI Labs): $179/mo starter, $199/mo advanced
- RedRock tirzepatide: $299-$399/mo (notably more expensive)
- Membership fee: none
- States: all 50
- LegitScript: certified
- Total Score (Master Sheet): 94/100, highest in dataset
The interactive per-pharmacy, per-dose pricing tool on Pomegranate’s site is unique. No other reviewed provider lets you see what each pharmacy partner charges at each dose before you create an account. Five partners listed: BPI Labs, Empower, Hallandale, RedRock, OptioRx.
How it runs. Use the pre-signup pricing page to pick pharmacy and dose. Async telehealth visit ($75 consult fee, credited to your first medication order). Labs required before month 2, paid out of pocket (insurance may cover). No subscription, no auto-charge. You reorder when you want.
Two real frictions. Pre-signup support is the known weak spot. Phone goes to voicemail on two attempts. After-hours chat routes to a different patient portal entirely. If you need to ask a question before signing up, you will struggle. Once you are a patient the CharmHealth-based portal is slow and bloated, lacking tracking and receipts. Two RedRock pharmacy locations have minor citation history (paid fines in 2023 and 2025). A $150 fee gets you a specific pharmacy guaranteed if you want one of the other four partners instead of being assigned. Shipping comes with two large non-sweat ice packs and tight insulated foam, which is the better end of the dataset.
Best if you want the lowest legitimate semaglutide price, you want to see the pharmacy name before you pay, and you’re comfortable researching on your own without a support phone tree.
[CTA: See current pricing →]
7. GobyMeds: Best Pre-Payment Pharmacy and Additive Disclosure
Pharmacy name and additive shown in the intake form, with hoverable explanations, before you enter a credit card. No other provider does this.
- True monthly cost: $169/mo semaglutide (monthly); $299/3mo, $399-499/3mo at higher dose
- Tirzepatide: $299/mo monthly; $399-599/3mo
- Pharmacy partners shown in intake: CasaPharmaRx, SevenCells, VitalRx (via PharmacyHub), BPI Labs (via PharmacyHub)
- Subscription: none. Order-when-ready model.
- States: all 50
- LegitScript: certified
- Total Score (Master Sheet): 89/100
If you’ve done your own research on additives (B12, B6, glycine, preservative-free) and you want to pick what’s in your compound, GobyMeds is the only path that surfaces that information before you enter payment. Hoverable pop-ups explain what each additive does. The closest thing to informed consent in the compounded telehealth market.
How it runs. Async intake form shows pharmacy plus additive options. You pick. Submit. Async clinical review. Medication ships when approved. Nothing auto-charges. You reorder when you want.
What to watch. Support is limited. Phone goes unanswered. Chat replies route to email with a 1-to-2-day turnaround. Clinical oversight is async-only, no live call, no video, and provider check-ins happen every 3 months minimum. A body photo is required during intake, which the master-sheet reviewer flagged as stigmatizing. CasaPharmaRX had 9 compliance deficiencies found August 2025, all corrected by January 2026 (the closed loop matters). The provider holds a Trustpilot 4.5 and a BBB B+. 24-hour delivery in the reviewer’s experience was fast, with one large ice pack and a bubble wrap pouch inside an insulated box.
Pick GobyMeds if you want to know exactly what’s in your vial before you pay, and you don’t need live clinical support.
[CTA: See current pricing →]
8. Enhance.MD: Best Compounded Path When You Want Real Clinical Oversight
Mandatory video visits every 30 days. Labs at month two and every six months. The compounded provider with the highest Safety & Legitimacy score in the data we reviewed.
- True monthly cost: $249/mo semaglutide (all doses); $329/mo tirzepatide
- Intro offer: first month as low as $49 (legitimate spring discount per Master Sheet)
- Pharmacy partners: Rite-Away, Vios Compounding, TruMedsRx (all clear disciplinary history)
- States excluded (10): AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
- LegitScript: certified
- BBB: A+ (1 complaint in 3 years, resolved)
- HSA/FSA: not accepted
- Total Score (Master Sheet): 81/100; Safety & Legitimacy 94/100 (highest in dataset)
This is the path for readers with a comorbidity (hypertension, pre-diabetes, family history of cardiovascular disease) or readers who’ve had bad experiences self-managing meds. Mandatory video appointments at 30-day preferred cadence (90-day minimum). Labs before month 2 and repeated every 6 months. One-on-one nutrition AND fitness coaching included as baseline, not as a paid add-on. Two coaches with open availability.
How it runs. Intake, first video visit, prescription, labs ordered before month 2, monthly follow-up video. Pricing is clear upfront on the Medication & Pricing tab. Phone is answered quickly during business hours.
Two frictions worth naming. First, 10 states excluded. If you live in Alabama, Arkansas, Georgia, Hawaii, Louisiana, Mississippi, Missouri, South Carolina, Tennessee, or West Virginia, this pick is closed to you. Use Pomegranate or GobyMeds instead. Second, the cancel button in the portal is a deceptive UX loop. Press it and the page tells you to call 888-299-5088. The phone is answered in reasonable time and the support is good quality, but the button design is a trick. Plan to cancel by phone with at least 5 business days of lead time.
The verdict on this one: best path if you want real provider accountability inside a compounded budget and you live outside the 10 excluded states.
[CTA: See current pricing →]
Verdict: Decision Tree, Skip-List, and the TrumpRx Context
Match your situation to a path.
- You want zero pharmacy-vetting and brand-name: LillyDirect Zepbound ($299/mo at 2.5mg, $449/mo flat at 7.5mg and up) or NovoCare Wegovy injection at $249/mo on the 12-month plan.
- You want the cheapest brand-name option and you can swallow a pill: Wegovy Pill at $149/mo (with the 30-minute fasting window) or Foundayo at $149/mo (no food rules, but newest molecule).
- You need below the $199 brand-name floor and you’re comfortable with compounded: Pomegranate at $119/mo semaglutide (Empower) or GobyMeds at $169/mo with pharmacy and additive disclosure before payment.
- You want clinical oversight built in: Enhance.MD at $249/mo, mandatory monthly video plus labs, outside the 10 excluded states.
Skip these three providers. RemedyMeds received an FDA Warning Letter on September 9, 2025 (reference 716830-09092025). Pharmacy undisclosed. BBB rating F. Lemonaid requires a credit card before intake (industry outlier on transparency) and shipped a soggy box with melted ice packs in the reviewer’s order. True monthly cost $348 with a hidden membership fee. Mochi packages medication inside a branded metal water bottle. The reviewer shook it trying to remove the ice packs, which degrades peptides. Advertised “$39 starting” is the membership fee only. True cost is $178/mo. BBB has logged a pattern-of-complaints alert. For the deeper case on each, see our cheapest tirzepatide online article on glp-1.us.com.
TrumpRx is real and not ranked. TrumpRx.gov launched February 5-6, 2026 as a federal portal that routes patients to participating providers offering most-favored-nation pricing. Semaglutide runs about $350/mo and tirzepatide about $346/mo. No income requirement. Medicare patients pay $245/mo or as low as $50/mo on some plans. We did not rank it because it requires a separate online consult with a participating provider, and the participating-provider list is not comprehensively published. For readers who specifically want brand-name semaglutide at a fixed price and who don’t mind extra navigation, TrumpRx is a viable parallel path. For everyone else, the eight picks above cover the situation matrix without the extra routing.
Pick the path that matches the friction you can absorb.
Frequently Asked Questions
Is compounded GLP-1 still legal in 2026?
Yes, but narrowly. 503A patient-specific compounding remains legal where documented clinical need exists, typically an excipient allergy or a dose strength not commercially available. The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025. On April 30, 2026, the FDA proposed removing GLP-1s from the 503B Bulks List, with public comment closing June 29, 2026. The providers ranked here operate under 503A with LegitScript certification and verifiable pharmacy partners.
Can I get Zepbound or Wegovy free through a patient assistance program?
No. As of April 2026, Lilly Cares Foundation does not list Zepbound. Novo Nordisk PAP explicitly excludes Wegovy and Saxenda, covering only diabetes medications including Ozempic. The lowest legitimate brand-name cost without PAP is Foundayo or Wegovy Pill at $149/mo, LillyDirect Zepbound 2.5mg at $299/mo, NovoCare Wegovy injection at $249/mo on the 12-month plan, or TrumpRx at about $346 to $350/mo.
What happens if I miss the 45-day refill window on LillyDirect Zepbound?
Pricing resets to non-program tiers. 7.5mg jumps from $449 to $599/mo (+$150). 10mg goes from $449 to $699 (+$250). 12.5mg goes from $449 to $849 (+$400). 15mg goes from $449 to $1,049 (+$600). The window is measured from the delivery date of your prior order, not from the date you finished the last vial. Set two calendar reminders: Day 30 to reorder, Day 40 to follow up if nothing has shipped.
Is TrumpRx a real program?
Yes. TrumpRx.gov launched February 5-6, 2026 as a federal portal routing patients to participating providers offering most-favored-nation prices on brand-name GLP-1s. Semaglutide runs about $350/mo, tirzepatide about $346/mo, and an oral GLP-1 initial dose around $150/mo. No income requirement. Medicare patients pay $245/mo, or as low as $50/mo copay on some plans. The participating-provider list is not comprehensively published, so expect some search friction.
What’s the difference between Wegovy Pill and Foundayo?
Wegovy Pill is oral semaglutide (Novo Nordisk). You take it 30 minutes before food with plain water only. Established semaglutide molecule. $149/mo for 1.5mg and 4mg through August 31, 2026. Foundayo is orforglipron (Eli Lilly). No food or water restrictions. FDA approved April 1, 2026. $149/mo starter via LillyDirect. Different drug class (non-peptide). Less long-term real-world data. Pick Foundayo if a fasting window would tank adherence. Pick Wegovy Pill for the more established molecule.
Is brand-name actually cheaper than compounded in 2026?
For tirzepatide at starter doses, LillyDirect $299/mo is matched by GobyMeds compounded at $299/mo and within about $120 of Pomegranate’s BPI Labs tirzepatide ($179-199/mo). For semaglutide, Wegovy Pill and Foundayo at $149/mo undercut most compounded semaglutide. Pomegranate at $119/mo with Empower is the only cheaper option in the dataset. Brand-name wins on quality assurance and zero pharmacy vetting. Compounded retains the lowest semaglutide floor at Pomegranate.